Global Specialty Enzymes Market is anticipated to witness a robust CAGR in the forecast period, 2024-2028.
Specialty enzymes are used in a variety of diagnostic procedures, including DNA sequencing and manipulation. The demand for enzymes in research & biotechnology, and pharmaceutical applications is expected to increase due to the projected decrease in the cost of DNA modification and sequencing.
Moreover, the increasing prevalence of digestive disorders such as indigestion, inflammation, and other diseases such as immunodeficiency and pain further propel the market. Specialty enzymes make it possible to address these problems quickly and effectively, and they have a wide range of applications in numerous industry sectors, which also helps the market expand. Additionally, the specialty enzymes market is anticipated to rise throughout the forecast period due to technical developments in specialty enzymes. Apart from these, favorable government policies for specialty enzymes and technological advancement for new applications propel the Global Specialty Enzymes Market in the forecast period.
Investments By Various Multinational Enzyme Manufacturers
Increasing Prevalence of Digestive Disorders
According to data from a new pan-European study, approximately 300 million people in Europe and the Mediterranean region are affected by digestive illnesses, and the related economic expenses are high. Additionally, between 2000 and 2019, all digestive disorders' incidence and mortality rates increased by 26% and 17%, respectively.
Investment in Biotechnology and Genetics by Various Multinational Enzyme Manufacturers
In 2022, the US Department of Agriculture (USDA) announced a new grant program to make USD500 million found at to support American fertilizer production, which can use biotechnology and biomanufacturing advances.
Download Free Sample Report
Market Segmentation
The Global Specialty Enzymes Market is segmented based on
Market Players
F. Hoffmann-La Roche AG, Codexis Inc., BASF SE, Koninklijke DSM N.V., DuPont Nutrition Biosciences, Advanced Enzyme Technologies Limited, Novozymes A/S, Amano Enzyme Inc., and Sekisui Diagnostics are some of the key players operating in the market.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, Volume in metric tons, and CAGR for 2018-2022 and 2023-2028 |
Report coverage | Revenue forecast, Volume Forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · Type · Source · Application |
Regional scope | North America, Europe, Asia Pacific, South America, Middle East & Africa |
Country scope | United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Colombia; Argentina; South Africa; UAE, Saudi Arabia, Qatar, Turkey, Egypt. |
Key companies profiled | F. Hoffmann-La Roche AG, Codexis Inc., BASF SE, Koninklijke DSM N.V., DuPont Nutrition Biosciences, Advanced Enzyme Technologies Limited, Novozymes A/S, Amano Enzyme Inc., and Sekisui Diagnostics |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |